Lumbrokinase
Commonly used for
Heart Health
Where to Buy
Our experts personally review each product we recommend for quality and cost effectiveness.
The cheapest product is usually low quality, but more expensive doesn’t always mean better.
The cheapest product is usually low quality, but more expensive doesn’t always mean better.
What is it? / Overview
Lumbrokinase degrades fibrin directly and is proposed to be more fibrin-specific than older thrombolytic enzymes, giving it a theoretically lower systemic bleeding risk -- a meta-analysis of largely Chinese trials found improved functional stroke-recovery scores without a significant rise in GI bleeding, but the evidence quality is variable and shouldn't be overstated as a general-wellness anticoagulant substitute.
How is it used? / Administration
Form: Lumbrokinase (a fibrinolytic enzyme complex from earthworms), enteric-coated capsules
Typical dose studied: Varies by product/units -- trials use enteric-coated capsules dosed several times daily
Timing: Typically on an empty stomach, enteric-coated
Ships trigger-empty -- fibrinolytic activity means this should never be positioned as a casual wellness supplement; despite claimed fibrin-specificity, the bleeding-risk interaction with antithrombotic drugs is the dominant safety consideration.
How well does it work? / Evidence
? Emerging / limited evidence
Who should avoid it?
Avoid with: Bleeding disorder / Coagulopathy; Chronic coronary disease / Coronary artery disease; Atrial fibrillation / Atrial flutter; Peripheral artery disease
Interacts with: Anticoagulants, antiplatelets, thrombolytics -- additive bleeding risk despite its claimed fibrin-specificity, the key interaction to flag
Already taking it? The largest evidence base is a meta-analysis of Chinese ischemic-stroke trials of variable quality -- reasonable to continue only under medical supervision given its fibrinolytic activity, and it should be stopped before any planned surgical procedure or period of active bleeding risk.
Research & references
Wiyarta E et al. (2025). Therapeutic Potential of Lumbrokinase in Acute Ischemic Stroke: A Meta-Analysis of Efficacy and Safety. Therapeutics and Clinical Risk Management.
Disclosure: Knozela is a participant in the Amazon Associates affiliate program. Some "Where to buy" links on this page are affiliate links -- if you make a purchase through them, Knozela may earn a commission at no additional cost to you.